Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by jag009  – NJ, 2020-02-04 19:43 (395 d 09:55 ago) – Posting: # 21145
Views: 1,344

» We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.
» Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Not sure if this answers your question(I think so but..):
Why not? For both safety and bioanalytical reasons.


Complete thread:

 Admin contact
21,370 posts in 4,463 threads, 1,495 registered users;
online 10 (0 registered, 10 guests [including 5 identified bots]).
Forum time: Saturday 05:38 CET (Europe/Vienna)

If debugging is the process of removing bugs,
then programming must be the process of putting them in.    Edsger W. Dijkstra

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz